Why the study?
Do plasmalogens and anionic phospholipids regulate the activity of the cardiac sarcolemmal sodium-calcium exchanger?
Do plasmalogens and anionic phospholipids regulate the activity of the cardiac sarcolemmal sodium-calcium exchanger?
Plasmalogens provide a critical lipid environment in which anionic phospholipids serve as boundary lipids for the regulation of the trans-sarcolemmal sodium-calcium exchanger.
Answers are grounded in this paper and cite their sources.
Plasmalogens may regulate cardiac NCX activity in vitro; leaves open physiologic relevance in myocytes or therapeutic implications.
Although plasmalogens are the predominant phospholipids of cardiac sarcolemma, their physiological role has not been forthcoming. Since the cardiac sarcolemmal sodium-calcium exchanger has been proposed to be regulated by anionic phospholipids, the roles of plasmalogens and anionic phospholipids as regulators of the sodium-calcium exchanger were explored. Reconstituted sodium-calcium exchange activity in plasmalogen-containing proteoliposomes was 10-fold higher than that in control proteoliposomes comprised of only diacyl phospholipids. Additionally, exchange activity in plasmalogen-containing proteoliposomes was regulated by anionic phospholipids. Thus, plasmalogens provide a critical lipid environment in which anionic phospholipids serve as boundary lipids for the regulation of the trans-sarcolemmal sodium-calcium exchanger.
No takes yet. Share an insight, caveat, or question.
Ford et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: